Actively Recruiting

Phase Not Applicable
Age: 20Years - 50Years
All Genders
NCT04344262

Small Doses Muscle Relaxant in General Anesthesia

Led by Mansoura University · Updated on 2024-02-06

60

Participants Needed

1

Research Sites

322 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study will be held to assess the effect of minimal dose muscle relaxant on postoperative pulmonary function. The time to extubation in minutes will be the primary outcome as a clinical indicator of the return of muscle power. The extubation time will be defined as the time from injecting the muscle relaxant reversing agent given when regain the train of four (TOF) ratio to 0.9 till removal of endotracheal tube. Intraoperative surgical conditions will be assessed in the form of surgeon satisfaction and the need for more muscle relaxant boluses. Postoperative complications as desaturation (peripheral oxygen saturation (Spo2) less than 90%), the need for re-intubation or ventilation support will be recorded. Patient lung will be assessed using ultrasound-based lung aeration score. Also, the diaphragmatic and intercostal muscle function will be assessed in the early postoperative period. Immediate postoperative pulmonary function tests will be evaluated using simple spirometer. Patients will be followed up for 28 days for detection of pulmonary complications.

CONDITIONS

Official Title

Small Doses Muscle Relaxant in General Anesthesia

Who Can Participate

Age: 20Years - 50Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adult patients aged from 20 to 50 years old
  • Scheduled for non-cardiothoracic surgery
  • Undergoing general anesthesia
  • Positioned in supine position during surgery
  • Provided informed consent to participate
Not Eligible

You will not qualify if you...

  • American Society of Anesthesiologists (ASA) score greater than 3
  • Suspected full stomach or surgery requiring profound muscle relaxation or dressing that interferes with ultrasound probe positioning
  • Presence of lung parenchymal disease
  • Kidney (renal) disease
  • Liver (hepatic) disease
  • Neuromuscular disease
  • Electrolyte imbalance
  • Taking medications that affect muscle contraction
  • Known allergy to any study drug

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Mansoura University-Emergency hospital-ICU

Al Mansurah, Egypt

Actively Recruiting

Loading map...

Research Team

M

Maha Ahmed Abo-Zeid, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here